S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
Log in

OTCMKTS:AUTRAutris Stock Price, Forecast & News

-0.01 (-37.78 %)
(As of 07/15/2020 04:00 PM ET)
Today's Range
Now: $0.01
50-Day Range N/A
52-Week Range
Now: $0.01
Volume286,881 shs
Average Volume109,537 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Autris, through its subsidiary, NitroHeat, LLC, assembles and supplies nitrogen generators, air filtration systems, compressed air heaters, and heated hoses. Its products include NitroMax30, a nitrogen generator producing 30cfm of pure nitrogen; HeatPro200, a compressed air heater for heating compressed air or nitrogen up to a maximum of 200f; MaxDry200, a tri stage filter, membrane dryer, and heater that is used to supply clean dry air for painting and other compressed air applications, including powder coating; and heated hoses, a sub component of the HeatPro200 and MaxDry200. The company supplies its products to automotive and industrial paint service providers, and industrial component manufacturers, as well as auto collision facilities through a distributor network in the United States, Canada, Holland, Germany, and China. Autris is based in Los Angeles, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars

Industry, Sector and Symbol

Industry Specialty Chemicals
Current SymbolOTCMKTS:AUTR



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive AUTR News and Ratings via Email

Sign-up to receive the latest news and ratings for AUTR and its competitors with MarketBeat's FREE daily newsletter.

Autris (OTCMKTS:AUTR) Frequently Asked Questions

How has Autris' stock been impacted by COVID-19 (Coronavirus)?

Autris' stock was trading at $0.0060 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, AUTR shares have increased by 133.3% and is now trading at $0.0140. View which stocks have been most impacted by Coronavirus.

Has Autris been receiving favorable news coverage?

Press coverage about AUTR stock has been trending extremely negative on Wednesday, according to InfoTrie Sentiment. The research group scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Autris earned a daily sentiment score of -4.3 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 3.0 out of 10, meaning that recent press coverage is unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Autris.

Who are some of Autris' key competitors?

Who are Autris' key executives?

Autris' management team includes the following people:
  • Mr. Anand Derek Naidoo, CEO, Pres & Director (Age 54)
  • Ms. Mirza Santillan, Corp. Sec. (Age 41)

What is Autris' stock symbol?

Autris trades on the OTCMKTS under the ticker symbol "AUTR."

How do I buy shares of Autris?

Shares of AUTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Autris' stock price today?

One share of AUTR stock can currently be purchased for approximately $0.01.

What is Autris' official website?

The official website for Autris is autris.net.

How can I contact Autris?

Autris' mailing address is 12021 Wilshire Blvd Ste 234, LOS ANGELES, CA 90025-1206, United States. The company can be reached via phone at +1-310-4301388.

This page was last updated on 7/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.